ARTICLE | Company News
Cureon, Oxagen target validation deal
December 6, 2001 8:00 AM UTC
Cureon (Copenhagen, Denmark) will use its SmArt-Validation target validation platform, which is based on Locked Nucleic Acid (LNA) antisense chemistry technology, to validate Oxagen gene targets. Oxag...